Skip to main content
. 2018 Feb 7;2018(2):CD012528. doi: 10.1002/14651858.CD012528.pub2

NCT02179983.

Trial name or title Tayside Rehabilitation in Bronchiectasis Exacerbations (TRIBE) : a randomized controlled trial (TRIBE)
Methods RCT of pulmonary rehabilitation after exacerbations of bronchiectasis
Participants Inclusion Criteria
  1. Bronchiectasis confirmed on High Resolution CT scan

  2. Clinical bronchiectasis confirmed by a respiratory physician. Documented exacerbation within the last year

  3. Independently mobile ‐ i.e. able to undertake pulmonary rehabilitation


Exclusion Criteria
  1. Inability to give informed consent to participate

  2. Age < 18 years

  3. Primary diagnosis of COPD

  4. Significant comorbidity that would limit the ability to undertake pulmonary rehabilitation ‐ i.e. cerebrovascular, cardiovascular or musculoskeletal disease

  5. CF

  6. Aortic aneurysm

  7. Recent myocardial infarction (within previous year)or unstable angina

Interventions
  1. No Intervention: standard care for exacerbation and follow‐up without rehabilitation

  2. Experimental: pulmonary rehabilitation (6 weeks of exercise and patient education after exacerbation)

Outcomes Primary Outcome Measures
  1. 6 minute walk distance


Secondary Outcome Measures
  1. Time to next exacerbation

  2. Quality of life ‐ St Georges respiratory questionnaire COPD assessment test

  3. Pulmonary function tests (FEV1, FVC, FEF25‐75)

  4. Respiratory symptoms ‐ patient diary cards

  5. Sputum microbiology

  6. 6 minute walk distance

Starting date June 2014
Contact information James D Chalmers, University of Dundee
Notes  

CF: cystic fibrosis; COPD: chronic obstructive pulmonary disorder; CT: computed tomographic; RCT: randomised controlled trial